Literature DB >> 4142574

The interaction of actinomycin with DNA.

I H Goldberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4142574     DOI： 10.1159/000392364

Source DB:  PubMed          Journal:  Antibiot Chemother (1971)        ISSN： 0066-4758


× No keyword cloud information.
  3 in total

1.  An evaluation of small-molecule p53 activators as chemoprotectants ameliorating adverse effects of anticancer drugs in normal cells.

Authors:  Ingeborg M M van Leeuwen; Bhavya Rao; Marijke C C Sachweh; Sonia Laín
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

2.  Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy.

Authors:  Bhavya Rao; Ingeborg M M van Leeuwen; Maureen Higgins; Johanna Campbel; Alastair M Thompson; David P Lane; Sonia Lain
Journal:  Oncotarget       Date:  2010-11

Review 3.  p53-Based cyclotherapy: exploiting the 'guardian of the genome' to protect normal cells from cytotoxic therapy.

Authors:  B Rao; S Lain; A M Thompson
Journal:  Br J Cancer       Date:  2013-11-14       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.